Literature DB >> 24850293

Multi-drug-resistant Klebsiella pneumoniae pancreatitis: a new challenge in a serious surgical infection.

Derin Tugal1, Melanie Lynch, Andrea M Hujer, Susan Rudin, Federico Perez, Robert A Bonomo.   

Abstract

BACKGROUND: Klebsiella pneumoniae is an important cause of nosocomial infections, but its role in severe acute pancreatitis (SAP) is not well defined. Few cases of K. pneumoniae associated SAP have been reported. Due to the emergence of extended-spectrum beta-lactamases (ESBLs) and carbapenemases, treatment of multidrug-resistant (MDR) K. pneumoniae presents a challenge. Tigecycline and colistin have gained recent attention for their broad-spectrum antimicrobial activity.
METHODS: We describe a case of SAP due to K. pneumoniae bearing K. pneumoniae carbapenemase (KPC) treated successfully with colistin plus tigecycline and offer a review of similar experiences published in the literature.
RESULTS: The case reported herein required surgical drainage of multiple pancreatic abscesses and treatment with tigecycline and colistin. Our comparative analysis revealed a number of unique features associated with SAP due to K. pneumoniae: 1) underlying pancreatic injury, 2) multiple drug resistance determinants and virulence factors that complicate treatment, and 3) surgical debridement as a requirement for cure.
CONCLUSION: As the prevalence of K. pneumoniae bearing KPC continues to increase in the healthcare setting, SAP caused by this MDR pathogen will become more common. Tigecycline plus colistin was a successful antibiotic regimen for the treatment of SAP due to K. pneumoniae bearing KPC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24850293      PMCID: PMC4394169          DOI: 10.1089/sur.2012.175

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  25 in total

Review 1.  Infected pancreatic necrosis.

Authors:  Renzo Dionigi; Francesca Rovera; Gianlorenzo Dionigi; Mario Diurni; Salvatore Cuffari
Journal:  Surg Infect (Larchmt)       Date:  2006       Impact factor: 2.150

2.  Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.

Authors:  Zubair A Qureshi; David L Paterson; Brian A Potoski; Mary C Kilayko; Gabriel Sandovsky; Emilia Sordillo; Bruce Polsky; Jennifer M Adams-Haduch; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

Review 3.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

4.  Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections.

Authors:  J A Passarell; A K Meagher; K Liolios; B B Cirincione; S A Van Wart; T Babinchak; E J Ellis-Grosse; P G Ambrose
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

Review 5.  Infections complicating pancreatitis: diagnosing, treating, preventing.

Authors:  W Uhl; R Isenmann; M W Büchler
Journal:  New Horiz       Date:  1998-05

Review 6.  Necrotizing pancreatitis.

Authors:  Steven J Hughes; Georgios I Papachristou; Michael P Federle; Kenneth K Lee
Journal:  Gastroenterol Clin North Am       Date:  2007-06       Impact factor: 3.806

Review 7.  Acute pancreatitis.

Authors:  Jean-Louis Frossard; Michael L Steer; Catherine M Pastor
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321

Review 8.  Tigecycline-induced acute pancreatitis: case report and literature review.

Authors:  Whitney Y Hung; Laura Kogelman; Gretchen Volpe; Mark Iafrati; Lisa Davidson
Journal:  Int J Antimicrob Agents       Date:  2009-06-18       Impact factor: 5.283

Review 9.  Necrotizing pancreatitis: diagnosis and management.

Authors:  John C Haney; Theodore N Pappas
Journal:  Surg Clin North Am       Date:  2007-12       Impact factor: 2.741

10.  Two cases of monomicrobial intraabdominal abscesses due to KPC--3 Klebsiella pneumoniae ST258 clone.

Authors:  Paola Di Carlo; Gianni Pantuso; Alessia Cusimano; Francesco D'Arpa; Anna Giammanco; Gaspare Gulotta; Adelfio M Latteri; Simona Madonia; Giuseppe Salamone; Caterina Mammina
Journal:  BMC Gastroenterol       Date:  2011-09-30       Impact factor: 3.067

View more
  6 in total

1.  Detection and genotype analysis of AmpC β-lactamase in Klebsiella pneumoniae from tertiary hospitals.

Authors:  Xiang-Qun Liu; Yong-Rui Liu
Journal:  Exp Ther Med       Date:  2016-04-27       Impact factor: 2.447

2.  Compositional and drug-resistance profiling of pathogens in patients with severe acute pancreatitis: a retrospective study.

Authors:  Ning Fan; Yong Hu; Hong Shen; Shengjie Liu; Guang Zhao; Lanju Sun; Chunyan Li; Xin Zhao; Yanning Li; Jianhua Wang; Yunfeng Cui
Journal:  BMC Gastroenterol       Date:  2020-12-01       Impact factor: 3.067

3.  Characteristics of and risk factors for biliary pathogen infection in patients with acute pancreatitis.

Authors:  Shayan Chen; Jiyu Shi; Minghui Chen; Jun Ma; Zhaowei Zeng; Rui Wang; Yunfeng Cui; Xue Gao
Journal:  BMC Microbiol       Date:  2021-10-05       Impact factor: 3.605

4.  Clinical Characteristics of Acute Pancreatitis Patients with Multidrug-Resistant Bacterial Infection.

Authors:  Guilan Cheng; Dingxi Wang; Ping Zhu; Ziqi Lin; Shichao Zhu; Juan Li; Linqian Li; Yipeng Zhang; Guixiang Li
Journal:  Infect Drug Resist       Date:  2022-03-31       Impact factor: 4.003

5.  Enterococcus hirae Bacteremia Associated with Acute Pancreatitis and Septic Shock.

Authors:  Peter V Dicpinigaitis; Manuel De Aguirre; Joseph Divito
Journal:  Case Rep Infect Dis       Date:  2015-08-31

6.  Management of multi drug resistant endogenous Klebsiella pneumoniae endophthalmitis with intravitreal and systemic colistin.

Authors:  Mohit Dogra; Mansi Sharma; Deeksha Katoch; Mangat Dogra
Journal:  Indian J Ophthalmol       Date:  2018-04       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.